Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus

Trial Profile

Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 19 Feb 2018

At a glance

  • Drugs AI 401 (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Feb 2018 The study has been completed in Italy.
    • 31 Jan 2018 The study has been completed in Sweden (end date: 2017-11-01)
    • 19 Jan 2018 This trial has been completed in Finland (end date: 2017-06-30)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top